{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T18:38:40Z","timestamp":1794335920637,"version":"4.9.0"},"reference-count":236,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T00:00:00Z","timestamp":1721347200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Enhancing livestock biosecurity is critical to safeguard the livelihoods of farmers, global and local economies, and food security. Vaccination is fundamental to the control and prevention of exotic and endemic high-priority infectious livestock diseases. Successful implementation of vaccination in a biosecurity plan is underpinned by a strong understanding of correlates of protection\u2014those elements of the immune response that can reliably predict the level of protection from viral challenge. While correlates of protection have been successfully characterized for many human viral vaccines, for many high-priority livestock viral diseases, including African swine fever and foot and mouth disease, they remain largely uncharacterized. Current literature provides insights into potential correlates of protection that should be assessed during vaccine development for these high-priority mammalian livestock viral diseases. Establishment of correlates of protection for biosecurity purposes enables immune surveillance, rationale for vaccine development, and successful implementation of livestock vaccines as part of a biosecurity strategy.<\/jats:p>","DOI":"10.3389\/fimmu.2024.1397780","type":"journal-article","created":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T04:30:09Z","timestamp":1721363409000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Defining correlates of protection for mammalian livestock vaccines against high-priority viral diseases"],"prefix":"10.3389","volume":"15","author":[{"given":"Samantha K.","family":"Davis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quentin G.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md. Tanjir","family":"Islam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Bean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Layton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David T.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacey E.","family":"Lynch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,7,19]]},"reference":[{"key":"B1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-030-69464-7_1","article-title":"Redefining Biosecurity by Application in Global Health, Biodefense, and Developing Technologies","volume-title":"Applied Biosecurity: Global Health, Biodefense, and Developing Technologies","author":"Burnette","year":"2021"},{"key":"B2","doi-asserted-by":"publisher","first-page":"2697","DOI":"10.3390\/ijerph15122697","article-title":"Improved biosafety and biosecurity measures and\/or strategies to tackle laboratory-acquired infections and related risks","volume":"15","author":"Peng","year":"2018","journal-title":"Int J Environ Res Public Health"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/fvets.2020.00167","article-title":"Using biosecurity measures to combat respiratory disease in cattle: The Norwegian control program for bovine respiratory syncytial virus and bovine coronavirus","volume":"7","author":"Stokstad","year":"2020","journal-title":"Front Veterinary Sci"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1111\/zph.12807","article-title":"The effectiveness of biosecurity interventions in reducing the transmission of bacteria from livestock to humans at the farm level: a systematic literature review","volume":"68","author":"Youssef","year":"2021","journal-title":"Zoonoses Public Health"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.3390\/vaccines9101136","article-title":"Vaccines and vaccination against lumpy skin disease","volume":"9","author":"Tuppurainen","year":"2021","journal-title":"Vaccines"},{"key":"B6","doi-asserted-by":"publisher","first-page":"473","DOI":"10.3390\/vaccines9050473","article-title":"Comparative evaluation of lumpy skin disease virus-based live attenuated vaccines","volume":"9","author":"Haegeman","year":"2021","journal-title":"Vaccines"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.01.035","article-title":"Evaluation of the safety, immunogenicity and efficacy of three capripoxvirus vaccine strains against lumpy skin disease virus","volume":"33","author":"Gari","year":"2015","journal-title":"Vaccine"},{"key":"B8","doi-asserted-by":"publisher","first-page":"33","DOI":"10.22067\/VETERINARY.V9I2.65381","article-title":"Immune response characteristics of Capri pox virus vaccines following emergency vaccination of cattle against lumpy skin disease virus","volume":"9","author":"Varshovi","year":"2017","journal-title":"Iranian J Veterinary Sci Technol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"102008","DOI":"10.1016\/j.cimid.2023.102008","article-title":"Long-term monitoring of immune response to recombinant lumpy skin disease virus in dairy cattle from small-household farms in western Thailand","volume":"99","author":"Suwankitwat","year":"2023","journal-title":"Comp Immunol Microbiol Infect Diseases"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12917-019-1831-y","article-title":"Humoral immune response to repeated lumpy skin disease virus vaccination and performance of serological tests","volume":"15","author":"Milovanovi\u0107","year":"2019","journal-title":"BMC veterinary Res"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1051008","article-title":"The immune response to lumpy skin disease virus in cattle is influenced by inoculation route","volume":"13","author":"Fay","year":"2022","journal-title":"Front Immunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1089\/vbz.2014.1698","article-title":"Vaccines for prevention of bluetongue and epizootic hemorrhagic disease in livestock: A North American perspective","volume":"15","author":"McVey","year":"2015","journal-title":"Vector-Borne Zoonotic Diseases"},{"key":"B13","doi-asserted-by":"publisher","first-page":"8762780","DOI":"10.1155\/2019\/8762780","article-title":"Comparative evaluation of T-cell immune response to BTV infection in sheep vaccinated with pentavalent btv vaccine when compared to un-vaccinated animals","volume":"2019","author":"Bitew","year":"2019","journal-title":"Veterinary Med Int"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.01.039","article-title":"Cell-mediated immune response and cross-protective efficacy of binary ethylenimine-inactivated bluetongue virus serotype-1 vaccine in sheep","volume":"28","author":"Umeshappa","year":"2010","journal-title":"Vaccine"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2009.09.070","article-title":"Seroconversion, neutralising antibodies and protection in bluetongue serotype 8 vaccinated sheep","volume":"27","author":"Oura","year":"2009","journal-title":"Vaccine"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2014.11.053","article-title":"Evaluation of adaptive immune responses and heterologous protection induced by inactivated bluetongue virus vaccines","volume":"33","author":"Breard","year":"2015","journal-title":"Vaccine"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fvets.2019.00407","article-title":"Prospects of next-generation vaccines for bluetongue","volume":"6","author":"Van Rijn","year":"2019","journal-title":"Front Veterinary Sci"},{"key":"B18","volume-title":"Virus infections of ruminants","author":"Erasmus","year":"1990"},{"key":"B19","article-title":"The use of vaccination in the control of bluetongue in southern Africa","volume":"40","author":"Dungu","year":"2004","journal-title":"Vet Ital"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1007\/s11259-015-9643-4","article-title":"Duration of protective immunity after a single vaccination with a live attenuated bivalent bluetongue vaccine","volume":"39","author":"Zhugunissov","year":"2015","journal-title":"Veterinary Res Commun"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0044619","article-title":"Bluetongue viruses based on modified-live vaccine serotype 6 with exchanged outer shell proteins confer full protection in sheep against virulent BTV8","volume":"7","author":"van Gennip","year":"2012","journal-title":"PLoS One"},{"key":"B22","article-title":"Neutralising antibody response in cattle after vaccination with monovalent modified-live vaccine against bluetongue virus serotype 2","volume":"40","author":"Savini","year":"2004","journal-title":"Vet Ital"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2009.10.027","article-title":"Heterologous prime boost vaccination with DNA and recombinant modified vaccinia virus Ankara protects IFNAR (\u2013\/\u2013) mice against lethal bluetongue infection","volume":"28","author":"Calvo-Pinilla","year":"2009","journal-title":"Vaccine"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1006\/viro.1996.0306","article-title":"Expression of the major core structural protein (VP7) of bluetongue virus, by a recombinant capripox virus, provides partial protection of sheep against a virulent heterotypic bluetongue virus challenge","volume":"220","author":"Wade-Evans","year":"1996","journal-title":"Virology"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2007.06.052","article-title":"Recombinant capripoxviruses expressing proteins of bluetongue virus: evaluation of immune responses and protection in small ruminants","volume":"25","author":"Perrin","year":"2007","journal-title":"Vaccine"},{"key":"B26","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S0165-2427(97)00084-6","article-title":"Antibody responses and protective immunity to recombinant vaccinia virus-expressed bluetongue virus antigens","volume":"59","author":"Lobato","year":"1997","journal-title":"Veterinary Immunol Immunopathol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1128\/iai.39.1.208-212.1983","article-title":"Passive protection of mice and sheep against bluetongue virus by a neutralizing monoclonal antibody","volume":"39","author":"Letchworth","year":"1983","journal-title":"Infection Immunity"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/S0034-5288(18)32007-1","article-title":"Role of neutralising antibody in passive immunity to bluetongue infection","volume":"36","author":"Jeggo","year":"1984","journal-title":"Res veterinary sci"},{"key":"B29","article-title":"Importance of ovine cytotoxic T cells in protection against bluetongue virus infection","volume":"178","author":"Jeggo","year":"1985","journal-title":"Prog Clin Biol Res"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.00101-23","article-title":"The timing and magnitude of the type I interferon response are correlated with disease tolerance in arbovirus infection","volume":"14","author":"Hardy","year":"2023","journal-title":"mBio"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1328820","article-title":"Specific T-cell subsets have a role in anti-viral immunity and pathogenesis but not viral dynamics or onwards vector transmission of an important livestock arbovirus","volume":"15","author":"Newbrook","year":"2024","journal-title":"Front Immunol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.3390\/vaccines9091020","article-title":"Evaluation of four commercial vaccines for the protection of piglets against the highly pathogenic porcine reproductive and respiratory syndrome virus (hp-PRRSV) QH-08 strain","volume":"9","author":"Ding","year":"2021","journal-title":"Vaccines"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1111\/j.1439-0450.2006.00965.x","article-title":"Long-term administration of a commercial porcine reproductive and respiratory syndrome virus (PRRSV)-inactivated vaccine in PRRSV-endemically infected sows","volume":"53","author":"Papatsiros","year":"2006","journal-title":"J Veterinary Med Ser B"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1746-6148-8-182","article-title":"Comparison of the efficacy of autogenous inactivated Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) vaccines with that of commercial vaccines against homologous and heterologous challenges","volume":"8","author":"Geldhof","year":"2012","journal-title":"BMC veterinary Res"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00007-18","article-title":"Recombinant porcine reproductive and respiratory syndrome virus expressing membrane-bound interleukin-15 as an immunomodulatory adjuvant enhances NK and \u03b3\u03b4 T cell responses and confers heterologous protection","volume":"92","author":"Cao","year":"2018","journal-title":"J Virol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.vetmic.2007.02.009","article-title":"Assessment of the efficacy of commercial porcine reproductive and respiratory syndrome virus (PRRSV) vaccines based on measurement of serologic response, frequency of gamma-IFN-producing cells and virological parameters of protection upon challenge","volume":"123","author":"Zuckermann","year":"2007","journal-title":"Veterinary Microbiol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.05.016","article-title":"Development of an 8-plex Luminex assay to detect swine cytokines for vaccine development: assessment of immunity after porcine reproductive and respiratory syndrome virus (PRRSV) vaccination","volume":"28","author":"Lawson","year":"2010","journal-title":"Vaccine"},{"key":"B38","doi-asserted-by":"publisher","first-page":"110170","DOI":"10.1016\/j.vetimm.2020.110170","article-title":"Immune responses induced by inactivated porcine reproductive and respiratory syndrome virus (PRRSV) vaccine in neonatal pigs using different adjuvants","volume":"232","author":"Vreman","year":"2021","journal-title":"Veterinary Immunol Immunopathol"},{"key":"B39","doi-asserted-by":"crossref","DOI":"10.1007\/978-0-387-33012-9_81","article-title":"Efficacy of an inactivated PRRSV vaccine: induction of virus-neutralizing antibodies and partial virological protection upon challenge","volume-title":"The Nidoviruses: Toward Control of SARS and other Nidovirus Diseases","author":"Misinzo","year":""},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.vetmic.2013.08.017","article-title":"Antibody response and maternal immunity upon boosting PRRSV-immune sows with experimental farm-specific and commercial PRRSV vaccines","volume":"167","author":"Geldhof","year":"2013","journal-title":"Veterinary Microbiol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1051\/vetres\/2009046","article-title":"Development of an experimental inactivated PRRSV vaccine that induces virus-neutralizing antibodies","volume":"40","author":"Vanhee","year":"2009","journal-title":"Veterinary Res"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1089\/vim.2005.18.381","article-title":"Porcine Reproductive and Respiratory Syndrome (PRRS) virus-specific interferon-\u03b3+ T-cell responses after PRRS virus infection or vaccination with an inactivated PRRS vaccine","volume":"18","author":"Piras","year":"2005","journal-title":"Viral Immunol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"185","DOI":"10.3390\/vaccines9020185","article-title":"Commercial PRRS modified-live virus vaccines","volume":"9","author":"Chae","year":"2021","journal-title":"Vaccines"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2009.03.028","article-title":"Efficacy of a modified live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine in pigs naturally exposed to a heterologous European (Italian cluster) field strain: Clinical protection and cell-mediated immunity","volume":"27","author":"Martelli","year":"2009","journal-title":"Vaccine"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2006.03.046","article-title":"Different European-type vaccines against porcine reproductive and respiratory syndrome virus have different immunological properties and confer different protection to pigs","volume":"351","author":"Diaz","year":"2006","journal-title":"Virology"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1111\/tbed.2018.65.issue-5","article-title":"A modified-live porcine reproductive and respiratory syndrome virus (PRRSV)-1 vaccine protects late-term pregnancy gilts against heterologous PRRSV-1 but not PRRSV-2 challenge","volume":"65","author":"Jeong","year":"2018","journal-title":"Transboundary emerging diseases"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1020227","article-title":"Systemic CD4 cytotoxic T cells improve protection against PRRSV-1 transplacental infection","volume":"13","author":"Li","year":"2023","journal-title":"Front Immunol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.dci.2016.04.019","article-title":"Immune responses to modified live virus vaccines developed from classical or highly pathogenic PRRSV following challenge with a highly pathogenic PRRSV strain","volume":"62","author":"Wang","year":"2016","journal-title":"Dev Comp Immunol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.vetmic.2014.05.030","article-title":"Evaluation of the efficacy of a new modified live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine (Fostera PRRS) against heterologous PRRSV challenge","volume":"172","author":"Park","year":"2014","journal-title":"Veterinary Microbiol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1038\/s41598-020-58626-y","article-title":"Cell-mediated immune response and protective efficacy of porcine reproductive and respiratory syndrome virus modified-live vaccines against co-challenge with PRRSV-1 and PRRSV-2","volume":"10","author":"Madapong","year":"2020","journal-title":"Sci Rep"},{"key":"B51","article-title":"Effectiveness of a commercial porcine reproductive and respiratory syndrome virus (PRRSV) subunit vaccine against heterologous PRRSV-1 and PRRSV-2 challenge in late-term pregnant gilts","volume":"83","author":"Oh","year":"2019","journal-title":"Can J Veterinary Res"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1099\/jgv.0.001492","article-title":"Construction and efficacy evaluation of novel swine leukocyte antigen (SLA) class I and class II allele-specific poly-T cell epitope vaccines against porcine reproductive and respiratory syndrome virus","volume":"101","author":"Tian","year":"2020","journal-title":"J Gen Virol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1292\/jvms.17-0583","article-title":"Comparative evaluation of the efficacy of commercial and prototype PRRS subunit vaccines against an HP-PRRSV challenge","volume":"80","author":"DT","year":"2018","journal-title":"J Veterinary Med Sci"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00304-06","article-title":"Protection against Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) Infection through Passive Transfer of PRRSV-Neutralizing Antibodies Is Dose Dependent","volume":"14","author":"Lopez","year":"2007","journal-title":"Clin Vaccine Immunol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.virusres.2018.01.015","article-title":"Porcine reproductive and respiratory syndrome virus neutralizing antibodies provide in vivo cross-protection to PRRSV1 and PRRSV2 viral challenge","volume":"248","author":"Robinson","year":"2018","journal-title":"Virus Res"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1007\/s00705-019-04216-x","article-title":"Foot-and-mouth disease vaccines: recent updates and future perspectives","volume":"164","author":"Kamel","year":"2019","journal-title":"Arch virol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.12.011","article-title":"The field effectiveness of routine and emergency vaccination with an inactivated vaccine against foot and mouth disease","volume":"31","author":"Elnekave","year":"2013","journal-title":"Vaccine"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0044365","article-title":"Interferon-\u03b3 induced by in vitro re-stimulation of CD4+ T-cells correlates with in vivo FMD vaccine induced protection of cattle against disease and persistent infection","volume":"7","author":"Oh","year":"2012","journal-title":"PLoS One"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2004.07.034","article-title":"Immune response characteristics following emergency vaccination of pigs against foot-and-mouth disease","volume":"23","author":"Barnard","year":"2005","journal-title":"Vaccine"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.rvsc.2009.02.008","article-title":"Quantification of water buffalo (Bubalus bubalis) cytokine expression in response to inactivated foot-and-mouth disease (FMD) vaccine","volume":"87","author":"Mingala","year":"2009","journal-title":"Res veterinary sci"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.02002-23","article-title":"Enhanced antigen-specific CD8 T cells contribute to early protection against FMDV through swine DC vaccination","volume":"98","author":"Mu","year":"2024","journal-title":"J Virol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.3389\/fvets.2022.1027006","article-title":"Predicting cross-protection against foot-and-mouth disease virus strains by serology after vaccination","volume":"9","author":"Gubbins","year":"2022","journal-title":"Front Veterinary Sci"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.68.11.7092-7098.1994","article-title":"Vaccines prepared from chimeras of foot-and-mouth disease virus (FMDV) induce neutralizing antibodies and protective immunity to multiple serotypes of FMDV","volume":"68","author":"Rieder","year":"1994","journal-title":"J virol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/0264-410X(92)90092-X","article-title":"Foot and mouth disease vaccine potency test in cattle: the interrelationship of antigen dose, serum neutralizing antibody response and protection from challenge","volume":"10","author":"Pay","year":"1992","journal-title":"Vaccine"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.3389\/fvets.2022.1033276","article-title":"Relationship between neutralizing and opsonizing monoclonal antibodies against foot-and-mouth disease virus","volume":"9","author":"Summerfield","year":"2022","journal-title":"Front Veterinary Sci"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-2427(98)00138-X","article-title":"Effective in vivo depletion of T cell subpopulations and loss of memory cells in cattle using mouse monoclonal antibodies","volume":"64","author":"Naessens","year":"1998","journal-title":"Veterinary Immunol immunopathol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1099\/vir.0.83417-0","article-title":"An MHC-restricted CD8+ T-cell response is induced in cattle by foot-and-mouth disease virus (FMDV) infection and also following vaccination with inactivated FMDV","volume":"89","author":"Guzman","year":"2008","journal-title":"J Gen Virol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.01029-23","article-title":"Characterization of T-cell subsets in response to foot-and-mouth disease bivalent inactivated vaccine in Chinese Holstein cows","volume":"11","author":"Zhang","year":"2023","journal-title":"Microbiol Spectrum"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.3389\/fvets.2020.554305","article-title":"Novel foot-and-mouth disease vaccine platform: formulations for safe and DIVA-compatible FMD vaccines with improved potency","volume":"7","author":"Hardham","year":"2020","journal-title":"Front Veterinary Sci"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.2217\/fvl.12.65","article-title":"Use of replication-defective adenoviruses to develop vaccines and biotherapeutics against foot-and-mouth disease","volume":"7","author":"Grubman","year":"2012","journal-title":"Future Virol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.77.2.1621-1625.2003","article-title":"Novel viral disease control strategy: adenovirus expressing alpha interferon rapidly protects swine from foot-and-mouth disease","volume":"77","author":"Chinsangaram","year":"2003","journal-title":"J virol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1089\/jir.2010.0055","article-title":"Porcine type I interferon rapidly protects swine against challenge with multiple serotypes of foot-and-mouth disease virus","volume":"31","author":"Dias","year":"2011","journal-title":"J Interferon Cytokine Res"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01874-09","article-title":"Interferon-induced protection against foot-and-mouth disease virus infection correlates with enhanced tissue-specific innate immune cell infiltration and interferon-stimulated gene expression","volume":"84","author":"Diaz-San Segundo","year":"2010","journal-title":"J virol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1016\/j.vetmic.2013.04.017","article-title":"Evaluation of the immune response elicited by vaccination with viral vectors encoding FMDV capsid proteins and boosted with inactivated virus","volume":"165","author":"Romanutti","year":"2013","journal-title":"Veterinary Microbiol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2005.04.014","article-title":"Rapid protection of cattle from direct challenge with foot-and-mouth disease virus (FMDV) by a single inoculation with an adenovirus-vectored FMDV subunit vaccine","volume":"337","author":"Pacheco","year":"2005","journal-title":"Virology"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2018.10.031","article-title":"Versatility of the adenovirus-vectored foot-and-mouth disease vaccine platform across multiple foot-and-mouth disease virus serotypes and topotypes using a vaccine dose representative of the AdtA24 conditionally licensed vaccine","volume":"36","author":"Barrera","year":"2018","journal-title":"Vaccine"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(01)00483-2","article-title":"Early protection against homologous challenge after a single dose of replication-defective human adenovirus type 5 expressing capsid proteins of foot-and-mouth disease virus (FMDV) strain A24","volume":"20","author":"Moraes","year":"2002","journal-title":"Vaccine"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0066134","article-title":"IFN-\u03b1 as an adjuvant for adenovirus-vectored FMDV subunit vaccine through improving the generation of T follicular helper cells","volume":"8","author":"Su","year":"2013","journal-title":"PloS One"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.10.037","article-title":"Increased efficacy of an adenovirus-vectored foot-and-mouth disease capsid subunit vaccine expressing nonstructural protein 2B is associated with a specific T cell response","volume":"29","author":"Moraes","year":"2011","journal-title":"Vaccine"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1089\/vim.2007.0031","article-title":"Protective immune responses against foot-and-mouth disease virus by vaccination with a DNA vaccine expressing virus-like particles","volume":"20","author":"Jin","year":"2007","journal-title":"Viral Immunol"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2018.02.012","article-title":"Systemic antibodies administered by passive immunization prevent generalization of the infection by foot-and-mouth disease virus in cattle after oronasal challenge","volume":"518","author":"Barrionuevo","year":"2018","journal-title":"Virology"},{"key":"B82","first-page":"187","article-title":"Opsonization-enhanced phagocytosis of foot-and-mouth disease virus","volume":"65","author":"McCullough","year":"1988","journal-title":"Immunology"},{"key":"B83","first-page":"421","article-title":"Immune protection against foot-and-mouth disease virus studied using virus-neutralizing and non-neutralizing concentrations of monoclonal antibodies","volume":"58","author":"McCullough","year":"1986","journal-title":"Immunology"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02017-19","article-title":"Development of a highly effective African swine fever virus vaccine by deletion of the I177L gene results in sterile immunity against the current epidemic Eurasia strain","volume":"94","author":"Borca","year":"2020","journal-title":"J Virol"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00554-15","article-title":"African swine fever virus Georgia isolate harboring deletions of MGF360 and MGF505 genes is attenuated in swine and confers protection against challenge with virulent parental virus","volume":"89","author":"O'Donnell","year":"2015","journal-title":"J virol"},{"key":"B86","doi-asserted-by":"publisher","first-page":"996","DOI":"10.3390\/pathogens11090996","article-title":"Taking a promising vaccine candidate further: efficacy of ASFV-G-\u0394MGF after intramuscular vaccination of domestic pigs and Oral vaccination of wild boar","volume":"11","author":"Deutschmann","year":"2022","journal-title":"Pathogens"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1010931","article-title":"Cross-protection against African swine fever virus upon intranasal vaccination is associated with an adaptive-innate immune crosstalk","volume":"18","author":"Bosch-Cam\u00f3s","year":"2022","journal-title":"PloS Pathogens"},{"key":"B88","doi-asserted-by":"publisher","first-page":"291","DOI":"10.3390\/v8100291","article-title":"Association of the host immune response with protection using a live attenuated African swine fever virus model","volume":"8","author":"Carlson","year":"2016","journal-title":"Viruses"},{"key":"B89","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.3390\/pathogens11121438","article-title":"A highly effective African swine fever virus vaccine elicits a memory T cell response in vaccinated swine","volume":"11","author":"Attreed","year":"2022","journal-title":"Pathogens"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-82-3-513","article-title":"The non-haemadsorbing African swine fever virus isolate ASFV\/NH\/P68 provides a model for defining the protective anti-virus immune response","volume":"82","author":"Leit\u00e3o","year":"2001","journal-title":"J Gen Virol"},{"key":"B91","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.3390\/pathogens11111311","article-title":"The Presence of Virus Neutralizing Antibodies Is Highly Associated with Protection against Virulent Challenge in Domestic Pigs Immunized with ASFV live Attenuated Vaccine Candidates","volume":"11","author":"Silva","year":"2022","journal-title":"Pathogens"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1099\/vir.0.81038-0","article-title":"In vivo depletion of CD8+ T lymphocytes abrogates protective immunity to African swine fever virus","volume":"86","author":"Oura","year":"2005","journal-title":"J Gen Virol"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1016\/j.vetimm.2005.10.005","article-title":"Perforin expression can define CD8 positive lymphocyte subsets in pigs allowing phenotypic and functional analysis of natural killer, cytotoxic T, natural killer T and MHC un-restricted cytotoxic T-cells","volume":"110","author":"Denyer","year":"2006","journal-title":"Veterinary Immunol immunopathol"},{"key":"B94","doi-asserted-by":"publisher","first-page":"443","DOI":"10.3390\/vaccines12040443","article-title":"Characterization of the protective cellular immune response in pigs immunized intradermally with the live attenuated African swine fever virus (ASFV) lv17\/WB\/rie1","volume":"12","author":"Pedrera","year":"2024","journal-title":"Vaccines"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1006\/viro.1998.9068","article-title":"The African swine fever virus proteins p54 and p30 are involved in two distinct steps of virus attachment and both contribute to the antibody-mediated protective immune response","volume":"243","author":"G\u00f3mez-Puertas","year":"1998","journal-title":"Virology"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0040942","article-title":"DNA vaccination partially protects against African swine fever virus lethal challenge in the absence of antibodies","volume":"7","author":"Argilaguet","year":"2012","journal-title":"PLoS One"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.3389\/fvets.2022.921481","article-title":"Adenovirus-vectored African swine fever virus pp220 induces robust antibody, IFN-\u03b3, and CTL responses in pigs","volume":"9","author":"Zajac","year":"2022","journal-title":"Front Veterinary Sci"},{"key":"B98","doi-asserted-by":"publisher","first-page":"2233643","DOI":"10.1080\/22221751.2023.2233643","article-title":"A new vaccination regimen using adenovirus-vectored vaccine confers effective protection against African swine fever virus in swine","volume":"12","author":"Liu","year":"2023","journal-title":"Emerging Microbes Infections"},{"key":"B99","doi-asserted-by":"publisher","first-page":"758","DOI":"10.3390\/v16050758","article-title":"Identification of an Immunodominant B-Cell Epitope in African Swine Fever Virus p30 Protein and Evidence of p30 Antibody-Mediated Antibody Dependent Cellular Cytotoxicity","volume":"16","author":"Noll","year":"2024","journal-title":"Viruses"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.3389\/fvets.2023.1208275","article-title":"Immunization of pigs with replication-incompetent adenovirus-vectored African swine fever virus multi-antigens induced humoral immune responses but no protection following contact challenge","volume":"10","author":"Zajac","year":"2023","journal-title":"Front Veterinary Sci"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.832264","article-title":"Vaccination with a gamma irradiation-inactivated African swine fever virus is safe but does not protect against a challenge","volume":"13","author":"Pikalo","year":"2022","journal-title":"Front Immunol"},{"key":"B102","doi-asserted-by":"publisher","first-page":"242","DOI":"10.3390\/vaccines9030242","article-title":"High doses of inactivated African swine fever virus are safe, but do not confer protection against a virulent challenge","volume":"9","author":"Cadenas-Fern\u00e1ndez","year":"2021","journal-title":"Vaccines"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2014.05.051","article-title":"Modern adjuvants do not enhance the efficacy of an inactivated African swine fever virus vaccine preparation","volume":"32","author":"Blome","year":"2014","journal-title":"Vaccine"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1016\/0165-2427(85)90071-6","article-title":"The role of antibody in protection against African swine fever virus","volume":"9","author":"Wardley","year":"1985","journal-title":"Veterinary Immunol immunopathol"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1016\/S0034-5288(18)32207-0","article-title":"Effector mechanisms in the pig. Antibody-dependent cellular cytolysis of African swine fever virus infected cells","volume":"35","author":"Norley","year":"1983","journal-title":"Res veterinary sci"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1006\/viro.1994.1040","article-title":"Passively transferred African swine fever virus antibodies protect swine against lethal infection","volume":"198","author":"Onisk","year":"1994","journal-title":"Virology"},{"key":"B107","doi-asserted-by":"publisher","first-page":"603","DOI":"10.3390\/vaccines10040603","article-title":"The development of classical swine fever marker vaccines in recent years","volume":"10","author":"Li","year":"2022","journal-title":"Vaccines"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1016\/j.vetmic.2017.01.012","article-title":"Efficacy evaluation of the C-strain-based vaccines against the subgenotype 2.1 d classical swine fever virus emerging in China","volume":"201","author":"Luo","year":"2017","journal-title":"Veterinary Microbiol"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-2427(01)00389-0","article-title":"The correlation of virus-specific interferon-gamma production and protection against classical swine fever virus infection","volume":"83","author":"Suradhat","year":"2001","journal-title":"Veterinary Immunol immunopathol"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1016\/0378-1135(88)90036-3","article-title":"The protective value of vaccine-induced neutralising antibody titres in swine fever","volume":"16","author":"Terpstra","year":"1988","journal-title":"Veterinary Microbiol"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(00)00347-9","article-title":"Chimeric (marker) C-strain viruses induce clinical protection against virulent classical swine fever virus (CSFV) and reduce transmission of CSFV between vaccinated pigs","volume":"19","author":"De Smit","year":"2001","journal-title":"Vaccine"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00415-13","article-title":"Assessment of the phenotype and functionality of porcine CD8 T cell responses following vaccination with live attenuated classical swine fever virus (CSFV) and virulent CSFV challenge","volume":"20","author":"Franzoni","year":"2013","journal-title":"Clin Vaccine Immunol"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2005.01.153","article-title":"A DNA vaccine expressing the E2 protein of classical swine fever virus elicits T cell responses that can prime for rapid antibody production and confer total protection upon viral challenge","volume":"23","author":"Ganges","year":"2005","journal-title":"Vaccine"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.02.029","article-title":"Characterisation of vaccine-induced, broadly cross-reactive IFN-\u03b3 secreting T cell responses that correlate with rapid protection against classical swine fever virus","volume":"30","author":"Graham","year":"2012","journal-title":"Vaccine"},{"key":"B115","doi-asserted-by":"publisher","first-page":"108403","DOI":"10.1016\/j.vetmic.2019.108403","article-title":"Commercial E2 subunit vaccine provides full protection to pigs against lethal challenge with 4 strains of classical swine fever virus genotype 2","volume":"237","author":"Gong","year":"2019","journal-title":"Veterinary Microbiol"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.09.073","article-title":"Human \u03b1IFN co-formulated with milk derived E2-CSFV protein induce early full protection in vaccinated pigs","volume":"28","author":"Toledo","year":"2010","journal-title":"Vaccine"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2018.10.030","article-title":"Enhanced protective immunity to CSFV E2 subunit vaccine by using IFN-\u03b3 as immunoadjuvant in weaning piglets","volume":"36","author":"Zhang","year":"2018","journal-title":"Vaccine"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1016\/j.rvsc.2014.01.002","article-title":"Cytokine and immunoglobulin isotype profiles during CP7_E2alf vaccination against a challenge with the highly virulent Koslov strain of classical swine fever virus","volume":"96","author":"Renson","year":"2014","journal-title":"Res Veterinary Sci"},{"key":"B119","doi-asserted-by":"publisher","first-page":"596","DOI":"10.3390\/ijms25010596","article-title":"Self-assembling E2-based nanoparticles improve vaccine thermostability and protective immunity against CSFV","volume":"25","author":"Song","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2021.01.142","article-title":"Broad neutralization of CSFV with novel monoclonal antibodies in vivo","volume":"173","author":"Xu","year":"2021","journal-title":"Int J Biol Macromolecules"},{"key":"B121","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/B978-0-12-802174-3.00002-3","article-title":"How vaccines work","volume-title":"The vaccine book","author":"Siegrist","year":"2016"},{"key":"B122","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.3390\/vaccines10081367","article-title":"Current vaccine platforms in enhancing T-cell response","volume":"10","author":"Ura","year":"2022","journal-title":"Vaccines"},{"key":"B123","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.3390\/vaccines9121490","article-title":"Vaccine technologies and platforms for infectious diseases: Current progress, challenges, and opportunities","volume":"9","author":"Ghattas","year":"2021","journal-title":"Vaccines"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1016\/j.provac.2011.10.009","article-title":"Veterinary vaccines and their importance to animal health and public health","volume":"5","author":"Roth","year":"2011","journal-title":"Proc Vaccinol"},{"key":"B125","article-title":"The use of vaccination in emergency animal disease responses","volume":"43","author":"Williams","year":"2007","journal-title":"Veterinaria Italiana"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jir327","article-title":"Global rinderpest eradication: lessons learned and why humans should celebrate too","volume":"204","author":"Morens","year":"2011","journal-title":"J Infect Diseases"},{"key":"B127","article-title":"Strategy for the control of foot-and-mouth disease in Uruguay","volume":"119","author":"Ugarte","year":"2004","journal-title":"Developments biologicals"},{"key":"B128","first-page":"51","article-title":"Foot-and-mouth disease control using vaccination: South African experience","volume":"119","author":"Br\u00fcckner","year":"2004","journal-title":"Developments biologicals"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1111\/tbed.14329","article-title":"African swine fever virus vaccine candidate ASFV-G-\u0394I177L efficiently protects European and native pig breeds against circulating Vietnamese field strain","volume":"69","author":"Tran","year":"2022","journal-title":"Transboundary Emerging Diseases"},{"key":"B130","unstructured":"Response strategy African swine fever Animal Health Australia Website2024"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1086\/589862","article-title":"Correlates of vaccine-induced immunity","volume":"47","author":"Plotkin","year":"2008","journal-title":"Clin Infect Diseases"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2022.10.017","article-title":"Sterilizing immunity: understanding COVID-19","volume":"55","author":"Wahl","year":"2022","journal-title":"Immunity"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00084-18","article-title":"Factors that influence the immune response to vaccination","volume":"32","author":"Zimmermann","year":"2019","journal-title":"Clin Microbiol Rev"},{"key":"B134","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.vetimm.2016.04.007","article-title":"Passive immunisation, an old idea revisited: Basic principles and application to modern animal production systems","volume":"174","author":"Hedegaard","year":"2016","journal-title":"Veterinary Immunol Immunopathol"},{"key":"B135","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/j.1751-0813.1994.tb03346.x","article-title":"Bluetongue virus infection in sheep: haematological changes and detection by polymerase chain reaction","volume":"71","author":"McColl","year":"1994","journal-title":"Aust veterinary J"},{"key":"B136","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S0165-2427(03)00004-7","article-title":"Induction of lymphopenia and inhibition of T cell function during acute infection of swine with foot and mouth disease virus (FMDV)","volume":"92","author":"Bautista","year":"2003","journal-title":"Veterinary Immunol immunopathol"},{"key":"B137","doi-asserted-by":"publisher","first-page":"239","DOI":"10.3390\/pathogens8040239","article-title":"Apoptosis, autophagy, and pyroptosis: immune escape strategies for persistent infection and pathogenesis of classical swine fever virus","volume":"8","author":"Ma","year":"2019","journal-title":"Pathogens"},{"key":"B138","article-title":"Study on clinical, haemato-biochemical changes in lumpy skin disease affected cattle in Bidar","volume":"11","author":"Shilpa","year":"2022","journal-title":"Pharma Innovation J"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-79-3-433","article-title":"Infection with foot-and-mouth disease virus results in a rapid reduction of MHC class I surface expression","volume":"79","author":"Sanz-Parra","year":"1998","journal-title":"J Gen virol"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0223955","article-title":"Mechanisms of African swine fever virus pathogenesis and immune evasion inferred from gene expression changes in infected swine macrophages","volume":"14","author":"Zhu","year":"2019","journal-title":"PloS One"},{"key":"B141","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s00705-006-0857-1","article-title":"Porcine reproductive and respiratory syndrome virus productively infects monocyte-derived dendritic cells and compromises their antigen-presenting ability","volume":"152","author":"Wang","year":"2007","journal-title":"Arch virol"},{"key":"B142","doi-asserted-by":"publisher","first-page":"130","DOI":"10.3390\/pathogens13020130","article-title":"Pathology and clinics of naturally occurring low-virulence variants of African swine fever emerged in domestic pigs in the South caucasus","volume":"13","author":"Avagyan","year":"2024","journal-title":"Pathogens"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00367","article-title":"The role of natural killer T cells in cancer\u2014a phenotypical and functional approach","volume":"9","author":"Krijgsman","year":"2018","journal-title":"Front Immunol"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1016\/j.cimid.2014.07.004","article-title":"Infection with foot-and-mouth disease virus (FMDV) induces a natural killer (NK) cell response in cattle that is lacking following vaccination","volume":"37","author":"Patch","year":"2014","journal-title":"Comp Immunol Microbiol Infect Diseases"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1089\/jir.2008.0058","article-title":"Activation of porcine natural killer cells and lysis of foot-and-mouth disease virus infected cells","volume":"29","author":"Toka","year":"2009","journal-title":"J Interferon Cytokine Res"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1016\/j.tvjl.2012.11.012","article-title":"Immunopathogenesis of porcine reproductive and respiratory syndrome in the respiratory tract of pigs","volume":"195","author":"G\u00f3mez-Laguna","year":"2013","journal-title":"Veterinary J"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.958307","article-title":"New insights in the interplay between African swine fever virus and innate immunity and its impact on viral pathogenicity","volume":"13","author":"Ayanwale","year":"2022","journal-title":"Front Microbiol"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2018.04.020","article-title":"Role of innate immunity in pathophysiology of classical swine fever virus infection","volume":"119","author":"Goraya","year":"2018","journal-title":"Microbial pathogenesis"},{"key":"B149","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1089\/vim.2007.0097","article-title":"Interferon-\u03b1 production by swine dendritic cells is inhibited during acute infection with foot-and-mouth disease virus","volume":"21","author":"Nfon","year":"2008","journal-title":"Viral Immunol"},{"key":"B150","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1089\/vim.2009.0078","article-title":"Loss of plasmacytoid dendritic cell function coincides with lymphopenia and viremia during foot-and-mouth disease virus infection","volume":"23","author":"Nfon","year":"2010","journal-title":"Viral Immunol"},{"key":"B151","doi-asserted-by":"publisher","first-page":"e23467","DOI":"10.1096\/fj.202301987RR","article-title":"Lumpy skin disease virus ORF127 protein suppresses type I interferon responses by inhibiting K63-linked ubiquitination of tank binding kinase 1","volume":"38","author":"Liang","year":"2024","journal-title":"FASEB J"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02697-13","article-title":"Type I interferon limits the capacity of bluetongue virus to infect hematopoietic precursors and dendritic cells in vitro and in vivo","volume":"88","author":"Rodr\u00edguez-Calvo","year":"2014","journal-title":"J Virol"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.01203","article-title":"Inhibition of African swine fever virus replication by porcine type I and type II interferons","volume":"11","author":"Fan","year":"2020","journal-title":"Front Microbiol"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1099\/vir.0.82585-0","article-title":"Recombinant swine beta interferon protects swine alveolar macrophages and MARC-145 cells from infection with Porcine reproductive and respiratory syndrome virus","volume":"88","author":"Overend","year":"2007","journal-title":"J Gen virol"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1016\/j.vetimm.2004.10.005","article-title":"Cloning and expression of interferon-\u03b1\/\u03b3 from a domestic porcine breed and its effect on classical swine fever virus","volume":"104","author":"Xia","year":"2005","journal-title":"Veterinary Immunol immunopathol"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.02326","article-title":"Early growth response gene-1 suppresses foot-and-mouth disease virus replication by enhancing type I interferon pathway signal transduction","volume":"9","author":"Zixiang","year":"2018","journal-title":"Front Microbiol"},{"key":"B157","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.vetmic.2017.03.014","article-title":"The viral innate immune antagonism and an alternative vaccine design for PRRS virus","volume":"209","author":"Ke","year":"2017","journal-title":"Veterinary Microbiol"},{"key":"B158","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.cytogfr.2007.01.016","article-title":"The relevance of cytokines for development of protective immunity and rational design of vaccines","volume":"18","author":"Chabalgoity","year":"2007","journal-title":"Cytokine Growth factor Rev"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1016\/j.virusres.2013.01.017","article-title":"Pathology of African swine fever: the role of monocyte-macrophage","volume":"173","author":"G\u00f3mez-Villamandos","year":"2013","journal-title":"Virus Res"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1016\/j.virusres.2012.11.009","article-title":"Cellular immunity in ASFV responses","volume":"173","author":"Takamatsu","year":"2013","journal-title":"Virus Res"},{"key":"B161","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13567-015-0275-z","article-title":"Live attenuated African swine fever viruses as ideal tools to dissect the mechanisms involved in viral pathogenesis and immune protection","volume":"46","author":"Lacasta","year":"2015","journal-title":"Veterinary Res"},{"key":"B162","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jcpa.2009.04.003","article-title":"The pathology and pathogenesis of bluetongue","volume":"141","author":"Maclachlan","year":"2009","journal-title":"J Comp pathol"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1016\/j.virusres.2013.09.040","article-title":"The immune response of ruminant livestock to bluetongue virus: from type I interferon to antibody","volume":"182","author":"Maclachlan","year":"2014","journal-title":"Virus Res"},{"key":"B164","first-page":"9","article-title":"Progress in research on inflammation and oxidative stress induced by PRRSV","volume":"60","author":"Zhang","year":"2021","journal-title":"Hubei Agric Sci"},{"key":"B165","article-title":"Immune response to lumpy skin disease virus: Host-virus interactions and immunopathogenesis","volume":"12","author":"Deepa","year":"2023","journal-title":"Parma Innovation J"},{"key":"B166","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5958\/0973-9149.2018.00002.3","article-title":"Immunopathogy of classical swine fever","volume":"20","author":"Barman","year":"2018","journal-title":"J Immunol Immunopathol"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.3389\/fvets.2015.00010","article-title":"Immune responses against classical swine fever virus: between ignorance and lunacy","volume":"2","author":"Summerfield","year":"2015","journal-title":"Front Veterinary Sci"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.02046","article-title":"Advances in foot-and-mouth disease virus proteins regulating host innate immunity","volume":"11","author":"Peng","year":"2020","journal-title":"Front Microbiol"},{"key":"B169","doi-asserted-by":"publisher","first-page":"101894","DOI":"10.1016\/j.cimid.2022.101894","article-title":"Cellular infiltration, cytokines, and histopathology of skin lesions associated with different clinical forms and stages of naturally occurring lumpy skin disease in cattle","volume":"90","author":"Badr","year":"2022","journal-title":"Comp Immunol Microbiol Infect Diseases"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.3389\/fvets.2020.601641","article-title":"Cytokine storm in domestic pigs induced by infection of virulent African swine fever virus","volume":"7","author":"Wang","year":"2021","journal-title":"Front veterinary sci"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1361531","article-title":"Infection of domestic pigs with a genotype II potent strain of ASFV causes cytokine storm and lymphocyte mass reduction","volume":"15","author":"Zuo","year":"2024","journal-title":"Front Immunol"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-2427(01)00243-4","article-title":"Differential production of proinflammatory cytokines: in vitro PRRSV and Mycoplasma hyopneumoniae co-infection model","volume":"79","author":"Thanawongnuwech","year":"2001","journal-title":"Veterinary Immunol immunopathol"},{"key":"B173","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.vetimm.2004.09.018","article-title":"Deciphering the involvement of innate immune factors in the development of the host response to PRRSV vaccination","volume":"102","author":"Royaee","year":"2004","journal-title":"Veterinary Immunol immunopathol"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.1099\/vir.0.19637-0","article-title":"Classical swine fever virus induces proinflammatory cytokines and tissue factor expression and inhibits apoptosis and interferon synthesis during the establishment of long-term infection of porcine vascular endothelial cells","volume":"85","author":"Bensaude","year":"2004","journal-title":"J Gen virol"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.1016\/j.rvsc.2013.09.011","article-title":"Classical swine fever virus infection modulates serum levels of INF-\u03b1, IL-8 and TNF-\u03b1 in 6-month-old pigs","volume":"95","author":"von Rosen","year":"2013","journal-title":"Res veterinary sci"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.1006\/viro.2002.1476","article-title":"The role of endothelial cell-derived inflammatory and vasoactive mediators in the pathogenesis of bluetongue","volume":"296","author":"DeMaula","year":"2002","journal-title":"Virology"},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.1016\/j.vetimm.2011.10.013","article-title":"Enhanced proinflammatory cytokine activity during experimental bluetongue virus-1 infection in Indian native sheep","volume":"145","author":"Channappanavar","year":"2012","journal-title":"Veterinary Immunol immunopathol"},{"key":"B178","article-title":"Serum concentration of some inflammatory cytokines, chemokines and proteins in holstein dairy cows affected with FMDV","volume":"12","author":"El-Karim","year":"2022","journal-title":"J Advanced Veterinary Res"},{"key":"B179","doi-asserted-by":"publisher","DOI":"10.1016\/j.vetmic.2012.06.025","article-title":"African swine fever virus excretion patterns in persistently infected animals: A quantitative approach","volume":"160","author":"de Carvalho Ferreira","year":"2012","journal-title":"Veterinary Microbiol"},{"key":"B180","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13567-017-0444-3","article-title":"Recall T cell responses to bluetongue virus produce a narrowing of the T cell repertoire","volume":"48","author":"Rojas","year":"2017","journal-title":"Veterinary Res"},{"key":"B181","doi-asserted-by":"publisher","first-page":"a016295","DOI":"10.1101\/cshperspect.a016295","article-title":"IL-6 in inflammation, immunity, and disease","volume":"6","author":"Tanaka","year":"2014","journal-title":"Cold Spring Harbor Perspect Biol"},{"key":"B182","doi-asserted-by":"publisher","first-page":"274","DOI":"10.3390\/pathogens11020274","article-title":"Adaptive cellular immunity against African swine fever virus infections","volume":"11","author":"Sch\u00e4fer","year":"2022","journal-title":"Pathogens"},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2024.1328177","article-title":"Immune cell early activation, apoptotic kinetic, and T-cell functional impairment in domestic pigs after ASFV CADC_HN09 strain infection","volume":"15","author":"Tian","year":"2024","journal-title":"Front Microbiol"},{"key":"B184","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01110","article-title":"Increased neutralizing antibody production and interferon-\u03b3 secretion in response to porcine reproductive and respiratory syndrome virus immunization in genetically modified pigs","volume":"8","author":"Huang","year":"2017","journal-title":"Front Immunol"},{"key":"B185","doi-asserted-by":"publisher","first-page":"233","DOI":"10.3390\/v15010233","article-title":"African swine fever virus infection and cytokine response in vivo: an update","volume":"15","author":"Franzoni","year":"2023","journal-title":"Viruses"},{"key":"B186","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1006\/viro.2002.1612","article-title":"Passive transfer of virus-specific antibodies confers protection against reproductive failure induced by a virulent strain of porcine reproductive and respiratory syndrome virus and establishes sterilizing immunity","volume":"302","author":"Osorio","year":"2002","journal-title":"Virology"},{"key":"B187","doi-asserted-by":"publisher","first-page":"108915","DOI":"10.1016\/j.vetmic.2020.108915","article-title":"Different clinical presentations of subgenotype 2.1 strain of classical swine fever infection in weaned piglets and adults, and long-term cross-protection conferred by a C-strain vaccine","volume":"253","author":"Wang","year":"2021","journal-title":"Veterinary Microbiol"},{"key":"B188","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2006.08.025","article-title":"Recombinant canarypox virus vaccine co-expressing genes encoding the VP2 and VP5 outer capsid proteins of bluetongue virus induces high level protection in sheep","volume":"25","author":"Boone","year":"2007","journal-title":"Vaccine"},{"key":"B189","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2019.03.082","article-title":"BTV antibody longevity in cattle five to eight years post BTV-8 vaccination","volume":"37","author":"Ries","year":"2019","journal-title":"Vaccine"},{"key":"B190","doi-asserted-by":"publisher","DOI":"10.1016\/S1286-4579(02)01634-9","article-title":"Aspects of the persistence of foot-and-mouth disease virus in animals\u2014the carrier problem","volume":"4","author":"Alexandersen","year":"2002","journal-title":"Microbes infection"},{"key":"B191","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.691145","article-title":"The ability of porcine reproductive and respiratory syndrome virus isolates to induce broadly reactive neutralizing antibodies correlates with in vivo protection","volume":"12","author":"Mart\u00ednez-Lobo","year":"2021","journal-title":"Front Immunol"},{"key":"B192","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2009.10.105","article-title":"Comparison of single, homologous prime-boost and heterologous prime-boost immunization strategies against H5N1 influenza virus in a mouse challenge model","volume":"28","author":"Sabarth","year":"2010","journal-title":"Vaccine"},{"key":"B193","article-title":"Immunologic response of sheep to inactivated and virulent bluetongue virus","volume":"46","author":"Stott","year":"1985","journal-title":"Am J veterinary Res"},{"key":"B194","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0143273","article-title":"Protective efficacy in sheep of adenovirus-vectored vaccines against bluetongue virus is associated with specific T cell responses","volume":"10","author":"Mart\u00edn","year":"2015","journal-title":"PloS One"},{"key":"B195","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2004.01.027","article-title":"Immunogenicity and T cell recognition in swine of foot-and-mouth disease virus polymerase 3D","volume":"322","author":"Garc\u0131\u00e1-Briones","year":"2004","journal-title":"Virology"},{"key":"B196","doi-asserted-by":"publisher","DOI":"10.1006\/viro.1999.9717","article-title":"Recombinant viruses expressing the foot-and-mouth disease virus capsid precursor polypeptide (P1) induce cellular but not humoral antiviral immunity and partial protection in pigs","volume":"259","author":"Sanz-Parra","year":"1999","journal-title":"Virology"},{"key":"B197","doi-asserted-by":"publisher","DOI":"10.1177\/104063879400600402","article-title":"Serum immune responses to the proteins of porcine reproductive and respiratory syndrome (PRRS) virus","volume":"6","author":"Nelson","year":"1994","journal-title":"J Veterinary Diagn Invest"},{"key":"B198","doi-asserted-by":"publisher","DOI":"10.1016\/j.virusres.2012.10.012","article-title":"Antibody-mediated neutralization of African swine fever virus: myths and facts","volume":"173","author":"Escribano","year":"2013","journal-title":"Virus Res"},{"key":"B199","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2003.11.011","article-title":"Neutralizing antibodies to African swine fever virus proteins p30, p54, and p72 are not sufficient for antibody-mediated protection","volume":"319","author":"Neilan","year":"2004","journal-title":"Virology"},{"key":"B200","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2021.1976580","article-title":"Building a better antibody through the Fc: advances and challenges in harnessing antibody Fc effector functions for antiviral protection","volume":"17","author":"Gunn","year":"2021","journal-title":"Hum Vaccines Immunotherapeutics"},{"key":"B201","doi-asserted-by":"publisher","DOI":"10.1080\/14728222.2021.1907343","article-title":"Targeting Fc effector function in vaccine design","volume":"25","author":"Richardson","year":"2021","journal-title":"Expert Opin Ther Targets"},{"key":"B202","doi-asserted-by":"publisher","first-page":"100510","DOI":"10.1016\/j.xcrm.2022.100510","article-title":"SARS-CoV-2 Beta and Delta variants trigger Fc effector function with increased cross-reactivity","volume":"3","author":"Richardson","year":"2022","journal-title":"Cell Rep Med"},{"key":"B203","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s00430-023-00773-w","article-title":"Antibody Fc-binding profiles and ACE2 affinity to SARS-CoV-2 RBD variants","volume":"212","author":"Haycroft","year":"2023","journal-title":"Med Microbiol Immunol"},{"key":"B204","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0270641","article-title":"The attenuated ASFV strains MK-200 and FK-32\/135 as possible models for investigation of protective immunity by ASFV infection","volume":"17","author":"Sereda","year":"2022","journal-title":"PloS One"},{"key":"B205","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2020.580096","article-title":"Intrinsic ADE: the dark side of antibody dependent enhancement during dengue infection","volume":"10","author":"Narayan","year":"2020","journal-title":"Front Cell Infection Microbiol"},{"key":"B206","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.3390\/v15071442","article-title":"Progress in PRRSV infection and adaptive immune response mechanisms","volume":"15","author":"Cai","year":"2023","journal-title":"Viruses"},{"key":"B207","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02180-10","article-title":"Foot-and-mouth disease virus exhibits an altered tropism in the presence of specific immunoglobulins, enabling productive infection and killing of dendritic cells","volume":"85","author":"Robinson","year":"2011","journal-title":"J Virol"},{"key":"B208","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3390\/vaccines7010012","article-title":"DNA-protein vaccination strategy does not protect from challenge with African swine fever virus Armenia 2007 strain","volume":"7","author":"Sunwoo","year":"2019","journal-title":"Vaccines"},{"key":"B209","doi-asserted-by":"publisher","DOI":"10.1126\/science.1185181","article-title":"Cross-reacting antibodies enhance dengue virus infection in humans","volume":"328","author":"Dejnirattisai","year":"2010","journal-title":"Science"},{"key":"B210","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.3390\/v14092021","article-title":"African swine fever vaccinology: the biological challenges from immunological perspectives","volume":"14","author":"Zhu","year":"2022","journal-title":"Viruses"},{"key":"B211","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.antiviral.2014.07.008","article-title":"VP2, VP7, and NS1 proteins of bluetongue virus targeted in avian reovirus muNS-Mi microspheres elicit a protective immune response in IFNAR (\u2013\/\u2013) mice","volume":"110","author":"Mar\u00edn-L\u00f3pez","year":"2014","journal-title":"Antiviral Res"},{"key":"B212","first-page":"207","article-title":"Synthesis of African swine fever (ASF) virus-specific antibodies in vitro in a porcine leucocyte system","volume":"62","author":"Casal","year":"1987","journal-title":"Immunology"},{"key":"B213","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1099\/vir.0.045732-0","article-title":"CD4+ T-cell responses to foot-and-mouth disease virus in vaccinated cattle","volume":"94","author":"Carr","year":"2013","journal-title":"J Gen Virol"},{"key":"B214","volume-title":"T cell-mediated cytotoxicity. Immunobiology: The Immune System in Health and Disease 5th edition","author":"Janeway","year":"2001"},{"key":"B215","first-page":"500","article-title":"Functional and phenotypic analysis of porcine peripheral blood CD4\/CD8 double-positive T cells","volume":"87","author":"Zuckermann","year":"1996","journal-title":"Immunology"},{"key":"B216","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.1966","article-title":"Interplay of foot and mouth disease virus with cell-mediated and humoral immunity of host","volume":"28","author":"Abubakar","year":"2018","journal-title":"Rev Med Virol"},{"key":"B217","doi-asserted-by":"publisher","first-page":"197980","DOI":"10.1016\/j.virusres.2020.197980","article-title":"Molecular and cellular mechanisms for PRRSV pathogenesis and host response to infection","volume":"286","author":"An","year":"2020","journal-title":"Virus Res"},{"key":"B218","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00350-20","article-title":"Absence of long-term protection in domestic pigs immunized with attenuated African swine fever virus isolate OURT88\/3 or Benin\u0394MGF correlates with increased levels of regulatory T cells and interleukin-10","volume":"94","author":"S\u00e1nchez-Cord\u00f3n","year":"2020","journal-title":"J Virol"},{"key":"B219","doi-asserted-by":"publisher","first-page":"508","DOI":"10.3390\/vaccines9050508","article-title":"M448R and MGF505-7R: two african swine fever virus antigens commonly recognized by ASFV-specific T-cells and with protective potential","volume":"9","author":"Bosch-Cam\u00f3s","year":"2021","journal-title":"Vaccines"},{"key":"B220","doi-asserted-by":"publisher","DOI":"10.1089\/vim.2017.0010","article-title":"Effects of vaccination with the C-strain vaccine on immune cells and cytokines of pigs against classical swine fever virus","volume":"31","author":"Xu","year":"2018","journal-title":"Viral Immunol"},{"key":"B221","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/925135","article-title":"CD4+ T cells: differentiation and functions","volume":"2012","author":"Luckheeram","year":"2012","journal-title":"Clin Dev Immunol"},{"key":"B222","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.virol.2012.04.009","article-title":"Porcine reproductive and respiratory syndrome virus induces CD4+ CD8+ CD25+ Foxp3+ regulatory T cells (Tregs)","volume":"430","author":"Silva-Campa","year":"2012","journal-title":"Virology"},{"key":"B223","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.vetmic.2016.11.007","article-title":"Up-regulation of IL-10 upon PRRSV vaccination impacts on the immune response against CSFV","volume":"197","author":"Wang","year":"2016","journal-title":"Veterinary Microbiol"},{"key":"B224","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.150012","article-title":"Simultaneous evaluation of antibodies that inhibit SARS-CoV-2 variants via multiplex assay","volume":"6","author":"Lopez","year":"2021","journal-title":"JCI Insight"},{"key":"B225","doi-asserted-by":"publisher","first-page":"114228","DOI":"10.1016\/j.jviromet.2021.114228","article-title":"Evaluation of a surrogate virus neutralization test for high-throughput serosurveillance of SARS-CoV-2","volume":"297","author":"Mari\u00ebn","year":"2021","journal-title":"J Virological Methods"},{"key":"B226","doi-asserted-by":"publisher","first-page":"4174","DOI":"10.1038\/s41467-023-39189-8","article-title":"Waning and boosting of antibody Fc-effector functions upon SARS-CoV-2 vaccination","volume":"14","author":"Tong","year":"2023","journal-title":"Nat Commun"},{"key":"B227","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2021.100296","article-title":"Decay of Fc-dependent antibody functions after mild to moderate COVID-19","volume":"2","author":"Lee","year":"2021","journal-title":"Cell Rep Med"},{"key":"B228","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.immuni.2022.01.001","article-title":"mRNA-1273 vaccine-induced antibodies maintain Fc effector functions across SARS-CoV-2 variants of concern","volume":"55","author":"Kaplonek","year":"2022","journal-title":"Immunity"},{"key":"B229","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3390\/vaccines9010035","article-title":"SARS-CoV-2 epitope mapping on microarrays highlights strong immune-response to N protein region","volume":"9","author":"Music\u00f2","year":"2021","journal-title":"Vaccines"},{"key":"B230","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abf7550","article-title":"SARS-CoV-2 genome-wide T cell epitope mapping reveals immunodominance and substantial CD8+ T cell activation in COVID-19 patients","volume":"6","author":"Saini","year":"2021","journal-title":"Sci Immunol"},{"key":"B231","first-page":"1","article-title":"Induction of effective cross-reactive immunity by FMDV peptides is critically dependent upon specific MHC-peptide-T cell interactions","volume":"82","author":"Glass","year":"1994","journal-title":"Immunology"},{"key":"B232","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00513","article-title":"Virus-induced T cell-mediated heterologous immunity and vaccine development","volume":"11","author":"Balz","year":"2020","journal-title":"Front Immunol"},{"key":"B233","volume-title":"Manual of Diagnostic Tests and Vaccines for Terrestrial Animals","year":"2023"},{"key":"B234","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2019.07.102","article-title":"Estimating the protection afforded by foot-and-mouth disease vaccines in the laboratory","volume":"37","author":"Paton","year":"2019","journal-title":"Vaccine"},{"key":"B235","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2018.1492378","article-title":"Foot and mouth disease vaccine strain selection: current approaches and future perspectives","volume":"17","author":"Mahapatra","year":"2018","journal-title":"Expert Rev Vaccines"},{"key":"B236","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.02130","article-title":"Viral emerging diseases: challenges in developing vaccination strategies","volume":"11","author":"Trovato","year":"2020","journal-title":"Front Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1397780\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T04:30:25Z","timestamp":1721363425000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1397780\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,19]]},"references-count":236,"alternative-id":["10.3389\/fimmu.2024.1397780"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2024.1397780","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,19]]},"article-number":"1397780"}}